Latest Biotech News

The Jackson Laboratory completed acquisition of the New York Stem Cell Foundation to create an integrated research and translational platform, the institutions said. The deal combines JAX’s...

The Congressional Budget Office (CBO) reported unexpected fiscal impacts from the Orphan Cures Act, raising a ten‑year cost estimate as three drugs drove larger‑than‑expected effects on price...

Replimune resubmitted its biologics license application for RP1, an engineered oncolytic herpes simplex virus combined with PD-1 blockade, and the FDA has accepted the filing with a target...

Grail entered a securities purchase agreement to raise approximately $325 million to fund commercial expansion and reimbursement efforts for its Galleri multi-cancer early-detection test. New and...

Exelixis said it will pursue a New Drug Application following Phase 3 STELLAR-303 results showing its oral TKI zanzalintinib plus atezolizumab reduced risk of death by about 20% versus regorafenib...

The FDA granted Roche an additional indication for Gazyva (obinutuzumab), approving the CD20-targeting antibody for treatment of lupus nephritis. The approval expands the agent's use beyond...

Anthropic launched Claude for Life Sciences, a domain-specialized large language model designed to assist researchers with tasks ranging from literature synthesis to querying complex datasets. The...

UC San Diego researchers described CANDiT, a machine‑learning systems biology framework that identifies targets to reprogram cancer stem cells toward differentiation and cell death. Applied to...

The Jackson Laboratory completed its acquisition of the New York Stem Cell Foundation, combining JAX’s genetics infrastructure with NYSCF’s human stem cell platforms. The transaction creates an...

Chugai Pharmaceutical signed a global collaboration and license with Rani Therapeutics to develop an oral product that pairs Rani’s Ranipill robotic delivery platform with a Chugai rare‑disease...

New FDA hiring data show the agency’s drug and biologics centers recorded nearly 1,000 net departures in the last quarter of fiscal 2025, marking a historic outflow that offsets hundreds of hires....

Researchers at the Allen Institute and UCSF developed CellTransformer, an AI neural network that classified 3.9 million mouse brain cells across >5,000 neuron types to produce a data‑driven brain...

Grail said Monday it has agreed a private placement expected to raise roughly $325 million to fund commercial expansion and reimbursement efforts for its Galleri circulating tumor DNA (ctDNA)...

Exelixis presented detailed STELLAR-303 Phase 3 data showing its oral TKI zanzalintinib plus Roche’s Tecentriq reduced the risk of death by about 20% versus Stivarga in previously treated...

ESMO presentations sharpened a head‑to‑head narrative between AstraZeneca/Daiichi Sankyo’s Datroway and Gilead’s Trodelvy in triple‑negative breast cancer and other difficult indications. At the...

Replimune said it has resubmitted data for RP1, its oncolytic therapy for melanoma, prompting the FDA to grant a second review with a new decision date set for April 10. The company’s resubmission...

Anthropic launched 'Claude for Life Sciences,' a large‑language model (LLM) tailored to research workflows, and announced collaborations with 10x Genomics and Benchling to integrate the model into...

Roche presented Phase 3 data showing ctDNA‑guided adjuvant Tecentriq prolonged survival for a subset of bladder cancer patients identified as high risk by a circulating tumor DNA test. The data,...

Researchers reported at ESMO and in accompanying analyses that mRNA COVID‑19 vaccines can enhance the efficacy of immune checkpoint inhibitors. MD Anderson presented retrospective data showing...

Chugai Pharmaceutical struck a global license and collaboration with Rani Therapeutics to develop an oral product combining Rani’s Ranipill robotic oral delivery technology with a Chugai...